GLP-1 RA microdosing uses doses below the smallest available commercial threshold typically starting at 0.1250.25 mg semaglutide weekly and often extends dosing intervals to every 10, 14, 21, or 28 days
Maridebart Cafraglutide (MariTide
Low Dose Naltrexone (LDN) EXPLORING THE USES OF LOW-DOSE NALTREXONE (LDN). Naltrexone, an opiate receptor antagonist, is not a new drug, but when used off label at very low doses, is a drug shown in many trials to be of therapeutic benefit
These come with their own complications around formulation for bioequivalence, stability, and loss of exclusivity which brings ambiguity to market access for those companies not able to secure a supply of pens
Orlistat and empagliflozin were selected as negative controls based on their similarity in the population indicated for GLP-1RAs, without any reported evidence of self-harm or suicide potential in the specification or related studies
Potential Side Effects and When to Seek Medical Advice B12 injections are generally well-tolerated, with serious adverse effects being rare